Elsevier, Bioorganic and Medicinal Chemistry Letters, 21(12), p. 3179-3182, 2002
DOI: 10.1016/s0960-894x(02)00639-x
Wiley-VCH Verlag, ChemInform, 9(34), 2003
Full text: Unavailable
FSCPX (1) and its amide analogue (2) have been reported to exhibit potent and selective irreversible antagonism of the A(1) adenosine receptor (A(1)AR) when used in in vitro biological preparations. In order to obtain an irreversible A(1)AR antagonist with improved stability, analogues of FSCPX incorporating the chemoreactive 4-(fluorosulfonyl)phenyl moiety separated from the xanthine pharmacophore by a ketone linkage were explored. Compounds 4a-c exhibited improved affinity for the A(1)AR and concentration-dependent irreversible binding to the A(1)AR.